372 related articles for article (PubMed ID: 7578182)
1. Methotrexate therapy for complex graft rejection in pediatric heart transplant recipients. The Pediatric Heart Transplant Team--Loma Linda.
Chinnock R; Emery J; Larsen R; Baum M; Janner D; Razzouk A; Gundry S; Nehlsen-Cannarella S; Bailey L
J Heart Lung Transplant; 1995; 14(4):726-33. PubMed ID: 7578182
[TBL] [Abstract][Full Text] [Related]
2. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients.
Costanzo MR; Koch DM; Fisher SG; Heroux AL; Kao WG; Johnson MR
J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA
J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929
[TBL] [Abstract][Full Text] [Related]
4. Treatment of recalcitrant cardiac allograft rejection with methotrexate. Cardiac Transplant Team.
Chan GL; Weinstein SS; Vijayanagar RR
Clin Transplant; 1995 Apr; 9(2):106-14. PubMed ID: 7599398
[TBL] [Abstract][Full Text] [Related]
5. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate pulse therapy in the treatment of recurrent acute heart rejection.
Bourge RC; Kirklin JK; White-Williams C; Naftel DC; George JF; Morrow R; Tarkka M; Welborn JM
J Heart Lung Transplant; 1992; 11(6):1116-24. PubMed ID: 1457434
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate for lung transplant recipients with steroid-resistant acute rejection.
Cahill BC; O'Rourke MK; Strasburg KA; Savik K; Jessurun J; Bolman RM; Hertz MI
J Heart Lung Transplant; 1996 Nov; 15(11):1130-7. PubMed ID: 8956122
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate therapy in pediatric heart transplantation as treatment of recurrent mild to moderate acute cellular rejection.
Shaddy RE; Bullock EA; Tani LY; Orsmond GS; Olsen SL; Taylor DO; McGough EC; Hawkins JA; Renlund DG
J Heart Lung Transplant; 1994; 13(6):1009-13. PubMed ID: 7865506
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate for the treatment of patients with multiple episodes of acute cardiac allograft rejection.
Hosenpud JD; Hershberger RE; Ratkovec RR; Hovaguimian H; Ott G; Cobanoglu A; Norman D
J Heart Lung Transplant; 1992; 11(4 Pt 1):739-45. PubMed ID: 1498141
[TBL] [Abstract][Full Text] [Related]
10. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
Hurwitz M; Desai DM; Cox KL; Berquist WE; Esquivel CO; Millan MT
Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate as rescue/adjunctive immunotherapy in infant and adult heart transplantation.
Bouchart F; Gundry SR; Van Schaack-Gonzales J; Razzouk AJ; Marsa RJ; Kawauchi M; de Begona JA; Bailey LL
J Heart Lung Transplant; 1993; 12(3):427-33. PubMed ID: 8329413
[TBL] [Abstract][Full Text] [Related]
12. Reversal of recalcitrant cardiac allograft rejection with methotrexate.
Costanzo-Nordin MR; Grusk BB; Silver MA; Sobotka PA; Winters GL; O'Connell JB; Pifarré R; Robinson JA
Circulation; 1988 Nov; 78(5 Pt 2):III47-57. PubMed ID: 3052918
[TBL] [Abstract][Full Text] [Related]
13. New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression.
Wagner K; Webber SA; Kurland G; Boyle GJ; Miller SA; Cipriani L; Griffith BP; Fricker FJ
J Heart Lung Transplant; 1997 Mar; 16(3):275-82. PubMed ID: 9087870
[TBL] [Abstract][Full Text] [Related]
14. Survival, graft atherosclerosis, and rejection incidence in heart transplant recipients treated with statins: 5-year follow-up.
Stojanovic I; Vrtovec B; Radovancevic B; Radovancevic R; Yazdanbakhsh AP; Thomas CD; Frazier OH
J Heart Lung Transplant; 2005 Sep; 24(9):1235-8. PubMed ID: 16143239
[TBL] [Abstract][Full Text] [Related]
15. Tacrolimus: a superior agent to OKT3 for treating cases of persistent rejection after intrathoracic transplantation.
Meiser BM; Uberfuhr P; Fuchs A; Schulze C; Nollert G; Mair H; Martin S; Pfeiffer M; Reichenspurner H; Kreuzer E; Reichart B
J Heart Lung Transplant; 1997 Aug; 16(8):795-800. PubMed ID: 9286771
[TBL] [Abstract][Full Text] [Related]
16. Cyclophosphamide in cardiac transplant recipients with frequent rejection: a six-year retrospective review.
Wagoner LE; Taylor DO; Olsen SL; Bristow MR; O'Connell JB; Hammond EH; Lappe DL; Renlund DG
Clin Transplant; 1996 Oct; 10(5):437-43. PubMed ID: 8930458
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate for rejection prophylaxis after heart transplantation.
Taylor DO; Olsen SL; Ensley RD; Renlund DG
J Heart Lung Transplant; 1995; 14(5):950-4. PubMed ID: 8800732
[TBL] [Abstract][Full Text] [Related]
18. Cardiac allograft rejection: do trough cyclosporine levels correlate with the grade of histologic rejection?
el Gamel A; Keevil B; Rahman A; Campbell C; Deiraniya A; Yonan N
J Heart Lung Transplant; 1997 Mar; 16(3):268-74. PubMed ID: 9087869
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate can halt the progression of bronchiolitis obliterans syndrome in lung transplant recipients.
Dusmet M; Maurer J; Winton T; Kesten S
J Heart Lung Transplant; 1996 Sep; 15(9):948-54. PubMed ID: 8889991
[TBL] [Abstract][Full Text] [Related]
20. Rabbit antithymocyte globulin as induction immunotherapy in pediatric heart transplantation.
Di Filippo S; Boissonnat P; Sassolas F; Robin J; Ninet J; Champsaur G; Bozio A
Transplantation; 2003 Feb; 75(3):354-8. PubMed ID: 12589158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
